| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.21 | 0.2 |